Literature DB >> 11062077

Dietary P(i) deprivation in rats affects liver cAMP, glycogen, key steps of gluconeogenesis and glucose production.

W Xie1, T L Tran, D T Finegood, G van de Werve.   

Abstract

We previously reported [Xie, Li, Méchin and van de Werve (1999) Biochem. J. 343, 393-396] that dietary phosphate deprivation for 2 days up-regulated both the catalytic subunit and the putative glucose-6-phosphate translocase of the rat liver microsomal glucose-6-phosphatase system, suggesting that increased hepatic glucose production might be responsible for the frequent clinical association of hypophosphataemia and glucose intolerance. We now show that liver cAMP was increased in rats fed with a diet deficient in P(i) compared with rats fed with a control diet. Accordingly, in the P(i)-deficient group pyruvate kinase was inactivated, the concentration of phosphoenolpyruvate was increased and fructose 2, 6-bisphosphate concentration was decreased. Phosphoenolpyruvate carboxykinase activity was marginally increased and glucokinase activity was unchanged by P(i) deprivation. The liver glycogen concentration decreased in the P(i)-deficient group. In the fed state, plasma glucose concentration was increased and plasma P(i) and insulin concentrations were substantially decreased in the P(i)-deficient group. All of these changes, except decreased plasma P(i), were cancelled in the overnight fasted P(i)-deficient group. In the fasted P(i)-deficient group, immediately after a glucose bolus, the plasma glucose level was elevated and the inhibition of endogenous glucose production was decreased. However, this mild glucose intolerance was not sufficient to affect the rate of fall of the glucose level after the glucose bolus. Taken together, these changes are compatible with a stimulation of liver gluconeogenesis and glycogenolysis by the P(i)-deficient diet and further indicate that the liver might contribute to impaired glucose homeostasis in P(i)-deficient states.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062077      PMCID: PMC1221451     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Glucose-6-phosphatase structure, regulation, and function: an update.

Authors:  J D Foster; B A Pederson; R C Nordlie
Journal:  Proc Soc Exp Biol Med       Date:  1997-09

2.  Stimulation of glucose-6-phosphatase gene expression by glucose and fructose-2,6-bisphosphate.

Authors:  D Argaud; T L Kirby; C B Newgard; A J Lange
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

3.  Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP.

Authors:  A J Lange; D Argaud; M R el-Maghrabi; W Pan; S R Maitra; S J Pilkis
Journal:  Biochem Biophys Res Commun       Date:  1994-05-30       Impact factor: 3.575

4.  Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib.

Authors:  I Gerin; M Veiga-da-Cunha; Y Achouri; J F Collet; E Van Schaftingen
Journal:  FEBS Lett       Date:  1997-12-15       Impact factor: 4.124

Review 5.  Covalent control of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: insights into autoregulation of a bifunctional enzyme.

Authors:  I J Kurland; S J Pilkis
Journal:  Protein Sci       Date:  1995-06       Impact factor: 6.725

6.  Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a.

Authors:  K J Lei; L L Shelly; C J Pan; J B Sidbury; J Y Chou
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

7.  Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions.

Authors:  M Nowicki; D Fliser; P Fode; E Ritz
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

8.  The co-localization of stanniocalcin protein, mRNA and kidney cell markers in the rat kidney.

Authors:  C K Wong; M A Ho; G F Wagner
Journal:  J Endocrinol       Date:  1998-08       Impact factor: 4.286

9.  Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats.

Authors:  K Y Trinh; R M O'Doherty; P Anderson; A J Lange; C B Newgard
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

10.  Effects of hypophosphatemia on glucose tolerance and insulin secretion.

Authors:  F J Paula; A E Plens; M C Foss
Journal:  Horm Metab Res       Date:  1998-05       Impact factor: 2.936

View more
  17 in total

Review 1.  Bone Remodeling and Energy Metabolism: New Perspectives.

Authors:  Francisco J A de Paula; Clifford J Rosen
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 2.  Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.

Authors:  Peter S N Rowe
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

Review 3.  A potential link between phosphate and aging--lessons from Klotho-deficient mice.

Authors:  Makoto Kuro-o
Journal:  Mech Ageing Dev       Date:  2010-03-01       Impact factor: 5.432

Review 4.  Klotho.

Authors:  Makoto Kuro-o
Journal:  Pflugers Arch       Date:  2010-01       Impact factor: 3.657

Review 5.  The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.

Authors:  Peter S N Rowe
Journal:  Cell Biochem Funct       Date:  2012-05-09       Impact factor: 3.685

6.  Phosphorus ingestion improves oral glucose tolerance of healthy male subjects: a crossover experiment.

Authors:  May Khattab; Christelle Abi-Rashed; Hala Ghattas; Sani Hlais; Omar Obeid
Journal:  Nutr J       Date:  2015-10-29       Impact factor: 3.271

7.  Renal localization and regulation by dietary phosphate of the MCT14 orphan transporter.

Authors:  Thomas Knöpfel; Alexander Atanassoff; Nati Hernando; Jürg Biber; Carsten A Wagner
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

8.  PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism.

Authors:  Lesya V Zelenchuk; Anne-Marie Hedge; Peter S N Rowe
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

Review 9.  Hyperphosphatemia Management in Patients with Chronic Kidney Disease.

Authors:  Ahmed M Shaman; Stefan R Kowalski
Journal:  Saudi Pharm J       Date:  2015-01-12       Impact factor: 4.330

10.  Phosphorus Supplementation Recovers the Blunted Diet-Induced Thermogenesis of Overweight and Obese Adults: A Pilot Study.

Authors:  Maya S Bassil; Omar A Obeid
Journal:  Nutrients       Date:  2016-12-09       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.